000 01478cam  2200337zi 4500
0019.888398
003CaOODSP
00520221107171959
006m     o  d f      
007cr |||||||||||
008200619e202004##onc     o    f000 0 eng d
020 |a9780660352879
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH13-9/5-2020E-PDF
24500|aGuidance document : |bmanagement of disinfectant drug applications.
264 1|a[Ottawa] : |bHealth Canada = Santé Canada, |cApril 2020.
264 4|c©2020
300 |a1 online resource (iv, 19 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Ligne directrice : gestion des présentations de désinfectants assimilés aux drogues (2020).
500 |a"Date adopted: 2018/01; revised date: 2019/12; effective date: 2020/04."
520 |a"This guidance document provides an overview of the application streams applicable to disinfectant drugs, including disinfectant-sanitizers"--Introduction, page 1.
650 0|aDisinfection and disinfectants|xCanada.
650 0|aDrug approval|zCanada.
7101 |aCanada. |bHealth Canada, |eissuing body.
77508|tLigne directrice : |w(CaOODSP)9.888399
795 |tGuidance document |w(CaOODSP)9.851101
85640|qPDF|s1.43 MB|uhttps://publications.gc.ca/collections/collection_2022/sc-hc/H13-9-5-2020-eng.pdf